Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

NCT01567085 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage V Chronic Kidney Disease

Interventions

DRUG: Eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.